bevacizumab,panitumumab
amgen,roche,takeda
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'paradigm']
paradigm trial folfox+pan better than folfox+bev in ras wt left sided mcrc pts #asco22 
MD, PhD. Medical Oncologist - Abdominal Medical Oncology Unit - INT Fondazione G. Pascale - Napoli